Purchases and Sales Made in Q4 2021 in Celyad Oncology Sa (CYAD)
This table provides information about the institutional ownership of Celyad Oncology Sa (CYAD) during Q4 2021. The information is specifically focused on institutions that hold shares of Celyad Oncology SA.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 14, 2022
Q4 2021
|
Fortress Investment Group LLC
New York, NY |
BUY
|
- |
6.5MNew |
$23.1M - $32.5M
|
6.5M
$3.38M
|
|
Feb 14, 2022
Q4 2021
|
Hrt Financial LP
New York, NY |
BUY
|
- |
38.1KNew |
$136K - $191K
|
38.1K
$19.8K
|
|
Feb 14, 2022
Q4 2021
|
Two Sigma Securities, LLC
New York, NY |
BUY
|
- |
17.8KNew |
$63.3K - $88.9K
|
17.8K
$9.25K
|
|
Feb 15, 2022
Q4 2021
|
Jane Street Group, LLC
New York, NY |
BUY
|
- |
11.1KNew |
$39.6K - $55.6K
|
11.1K
$5.78K
|
|
Feb 14, 2022
Q4 2021
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
10.9K+ 139.37% |
$38.6K - $54.3K
|
18.6K
$9.69K
|
|
Jan 24, 2022
Q4 2021
|
National Bank Of Canada
|
BUY
|
- |
3.4KNew |
$12.1K - $17K
|
3.4K
$1.77K
|
|
Feb 14, 2022
Q4 2021
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
1.23KNew |
$4.36K - $6.13K
|
1.23K
$637
|
|
Feb 07, 2022
Q4 2021
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Feb 08, 2022
Q4 2021
|
Ranch Capital Advisors Inc.
Sarasota, FL |
SELL
|
- |
-4Closed |
$14.2 - $20
|
0
$0
|
|
Feb 14, 2022
Q4 2021
|
Ubs Group Ag
|
SELL
|
- |
-812- 18.49% |
$2.89K - $4.06K
|
3.58K
$1.86K
|
|
Feb 14, 2022
Q4 2021
|
Morgan Stanley
New York, NY |
SELL
|
- |
-862- 3.47% |
$3.07K - $4.31K
|
24K
$12.5K
|
|
Feb 10, 2022
Q4 2021
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-3KClosed |
$10.7K - $15K
|
0
$0
|
|
Feb 14, 2022
Q4 2021
|
Endurant Capital Management LP
San Mateo, CA |
SELL
|
- |
-145KClosed |
$518K - $727K
|
0
$0
|